Torrent Pharmaceuticals is setting up a separate subsidiary in Poland to focus on Eastern European markets and has firmed up marketing alliances with two European companies for marketing generic formulations shortly going off-patent in Europe
Published:
7 November 2003 y., Friday
According to sources, TPL has already appointed Krystof Bernt as v-p and MD to head its Eastern European operations, which will be headquartered at Warsaw in Poland.
The new subsidiary would be TPL’s second European arm after it incorporated a wholly owned subsidiary Torrent Pharma GmbH in Germany last fiscal year.
For marketing alliances, TPL has entered into an agreement with $ 1.28 billion speciality formulations player Alpharma.
Šaltinis:
TIMES NEWS NETWORK
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.